Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF
October 12, 2023 at 06:00 pm IST
Share
Cryoport, Inc. announced that the Company has signed a new three-year supply chain solutions agreement with Monash IVF Group Limited as well as specialist women's imaging and diagnostic services in Australia and Southeast Asia.Through this multi-year agreement, Monash IVF and its operating businesses will utilize Cryoport's cryogenic logistics solutions and ISO- certified risk mitigation process for the delivery of patients' reproductive materials throughout Australia and internationally. Repromed materials may be moved from one clinic to another due to costs, a patients' personal move, access to specific donor materials, for storage purposes and more.
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Companyâs supply chain solutions enable manufacturers, contract manufacturers (CDMOâs), contract research organizations (CROâs), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.